PEOPLE - NuGEN Technologies (US) makes appointment:
This article was originally published in Clinica
NuGEN Technologies (San Carlos, California), a developer and commercialiser of genetic and proteomic analysis products and technologies that generate a better understanding, diagnosis and treatment of disease, has appointed Inder Verma to its scientific advisory board. Dr Verma currently serves as an American Cancer Society Professor of Molecular Biology in the laboratory of genetics at the Salk Institute and an Adjunct Professor in the department of biology at the University of California, San Diego.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.